Insider trade

Labcorp (LH)Officer sold ~$330K

van der Vaart Sandra D, Officer at Labcorp, sold ~$330K of Labcorp shares.

~$330K
Approx. value · 1,314 sh @ $251.30
2,170.54
Holds after · shares reported
Traded
Feb 25, 2025
Filed
Feb 27, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 7, 2025InsiderDirector sold ~$235K of LH shares in the open market
  2. Feb 5, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  3. Feb 8, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  4. Feb 11, 2025InsiderCEO sold ~$1.5M of LH shares in the open market
  5. Feb 17, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  6. Feb 18, 2025InsiderOfficer sold ~$348K of LH shares in the open market
  7. Feb 24, 2025InsiderOfficer sold ~$57K of LH shares in the open market
  8. Feb 25, 2025 · this disclosureInsiderOfficer sold ~$330K of LH shares in the open market

What came next

  1. Feb 25, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  2. Feb 27, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  3. Feb 28, 2025InsiderOfficer sold ~$1.33M of LH shares in the open market
  4. Feb 28, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  5. Mar 5, 2025InsiderDirector sold ~$128K of LH shares in the open market
  6. Mar 28, 2025Insider · 2 peopleInsiders: 2 sales (~$786K)
  7. Mar 31, 2025CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
  8. Apr 8, 2025CongressDisclosed sale of LH — reported range $1,001 - $15,000
  9. May 1, 2025Insider · 2 peopleInsiders: 2 sales (~$654K)
  10. May 12, 2025InsiderCEO sold ~$1.52M of LH shares in the open market
  11. May 15, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  12. Jun 3, 2025InsiderOfficer sold ~$494K of LH shares in the open market
  13. Jun 11, 2025InsiderDirector sold ~$130K of LH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Labcorp

For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

Other recent filings by van der Vaart Sandra D, EVP, Chief Legal Officer

The full history of van der Vaart Sandra D, EVP, Chief Legal Officer is on the profile page.

How this filing works

Other disclosures at Labcorp

Everything OQRO holds on this company is on its LH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data